Kymera Therapeutics, Inc. (KYMR)

78.02 -2.33 (-2.90%) USD  |  NASDAQ  |  Dec 30, 12:12
More

Kymera Therapeutics Current Deferred Revenue (Quarterly)

Current Deferred Revenue (Quarterly) Chart

View Current Deferred Revenue (Quarterly) for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Deferred Revenue (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Deferred Revenue (Quarterly) Range, Past 5 Years

View Current Deferred Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Deferred Revenue (Quarterly) Benchmarks

View Current Deferred Revenue (Quarterly) Benchmarks
Start Trial
Gilead Sciences, Inc. --
Regeneron Pharmaceuticals, Inc. Upgrade
Cytokinetics, Inc. Upgrade
TG Therapeutics, Inc. Upgrade
Protagonist Therapeutics, Inc. Upgrade